Cargando…

Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility

Infections caused by Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates, such as hospital-acquired pneumonia (HAP), bacteremia, and skin and soft tissue infections, among others, are particularly challenging to treat. Cefiderocol, a chlorocatechol-substituted siderophore antibiotic, was ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Mezcord, Vyanka, Escalante, Jenny, Nishimura, Brent, Traglia, German M., Sharma, Rajnikant, Vallé, Quentin, Tuttobene, Marisel R., Subils, Tomás, Marin, Ingrid, Pasteran, Fernando, Actis, Luis A., Tolmasky, Marcelo E., Bonomo, Robert A., Rao, Gauri, Ramirez, María S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380697/
https://www.ncbi.nlm.nih.gov/pubmed/37511511
http://dx.doi.org/10.3390/ijms241411752
_version_ 1785080260167991296
author Mezcord, Vyanka
Escalante, Jenny
Nishimura, Brent
Traglia, German M.
Sharma, Rajnikant
Vallé, Quentin
Tuttobene, Marisel R.
Subils, Tomás
Marin, Ingrid
Pasteran, Fernando
Actis, Luis A.
Tolmasky, Marcelo E.
Bonomo, Robert A.
Rao, Gauri
Ramirez, María S.
author_facet Mezcord, Vyanka
Escalante, Jenny
Nishimura, Brent
Traglia, German M.
Sharma, Rajnikant
Vallé, Quentin
Tuttobene, Marisel R.
Subils, Tomás
Marin, Ingrid
Pasteran, Fernando
Actis, Luis A.
Tolmasky, Marcelo E.
Bonomo, Robert A.
Rao, Gauri
Ramirez, María S.
author_sort Mezcord, Vyanka
collection PubMed
description Infections caused by Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates, such as hospital-acquired pneumonia (HAP), bacteremia, and skin and soft tissue infections, among others, are particularly challenging to treat. Cefiderocol, a chlorocatechol-substituted siderophore antibiotic, was approved by the U.S. Food and Drug Administration (FDA) in 2019 and prescribed for the treatment of CRAB infections. Despite the initial positive treatment outcomes with this antimicrobial, recent studies reported a higher-than-average all-cause mortality rate in patients treated with cefiderocol compared to the best available therapy. The cause(s) behind these outcomes remains unconfirmed. A plausible hypothesis is heteroresistance, a phenotype characterized by the survival of a small proportion of cells in a population that is seemingly isogenic. Recent results have demonstrated that the addition of human fluids to CRAB cultures leads to cefiderocol heteroresistance. Here, we describe the molecular and phenotypic analyses of CRAB heteroresistant bacterial subpopulations to better understand the nature of the less-than-expected successful outcomes after cefiderocol treatment. Isolation of heteroresistant variants of the CRAB strain AMA40 was carried out in cultures supplemented with cefiderocol and human pleural fluid (HPF). Two AMA40 variants, AMA40 IHC1 and IHC2, were resistant to cefiderocol. To identify mutations and gene expression changes associated with cefiderocol heteroresistance, we subjected these variants to whole genome sequencing and global transcriptional analysis. We then assessed the impact of these mutations on the pharmacodynamic activity of cefiderocol via susceptibility testing, EDTA and boronic acid inhibition analysis, biofilm formation, and static time-kill assays. Heteroresistant variants AMA40 IHC1 and AMA40 IHC2 have 53 chromosomal mutations, of which 40 are common to both strains. None of the mutations occurred in genes associated with high affinity iron-uptake systems or β-lactam resistance. However, transcriptional analyses demonstrated significant modifications in levels of expression of genes associated with iron-uptake systems or β-lactam resistance. The bla(NDM-1) and bla(ADC-2,) as well as various iron-uptake system genes, were expressed at higher levels than the parental strain. On the other hand, the carO and ompA genes’ expression was reduced. One of the mutations common to both heteroresistant strains was mapped within ppiA, a gene associated with iron homeostasis in other species. Static time-kill assays demonstrated that supplementing cation-adjusted Mueller–Hinton broth with human serum albumin (HAS), the main protein component of HPF, considerably reduced cefiderocol killing activity for all three strains tested. Notably, collateral resistance to amikacin was observed in both variants. We conclude that exposing CRAB to fluids with high HSA concentrations facilitates the rise of heteroresistance associated with point mutations and transcriptional upregulation of genes coding for β-lactamases and biofilm formation. The findings from this study hold significant implications for understanding the emergence of CRAB resistance mechanisms against cefiderocol treatment. This understanding is vital for the development of treatment guidelines that can effectively address the challenges posed by CRAB infections.
format Online
Article
Text
id pubmed-10380697
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103806972023-07-29 Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility Mezcord, Vyanka Escalante, Jenny Nishimura, Brent Traglia, German M. Sharma, Rajnikant Vallé, Quentin Tuttobene, Marisel R. Subils, Tomás Marin, Ingrid Pasteran, Fernando Actis, Luis A. Tolmasky, Marcelo E. Bonomo, Robert A. Rao, Gauri Ramirez, María S. Int J Mol Sci Article Infections caused by Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates, such as hospital-acquired pneumonia (HAP), bacteremia, and skin and soft tissue infections, among others, are particularly challenging to treat. Cefiderocol, a chlorocatechol-substituted siderophore antibiotic, was approved by the U.S. Food and Drug Administration (FDA) in 2019 and prescribed for the treatment of CRAB infections. Despite the initial positive treatment outcomes with this antimicrobial, recent studies reported a higher-than-average all-cause mortality rate in patients treated with cefiderocol compared to the best available therapy. The cause(s) behind these outcomes remains unconfirmed. A plausible hypothesis is heteroresistance, a phenotype characterized by the survival of a small proportion of cells in a population that is seemingly isogenic. Recent results have demonstrated that the addition of human fluids to CRAB cultures leads to cefiderocol heteroresistance. Here, we describe the molecular and phenotypic analyses of CRAB heteroresistant bacterial subpopulations to better understand the nature of the less-than-expected successful outcomes after cefiderocol treatment. Isolation of heteroresistant variants of the CRAB strain AMA40 was carried out in cultures supplemented with cefiderocol and human pleural fluid (HPF). Two AMA40 variants, AMA40 IHC1 and IHC2, were resistant to cefiderocol. To identify mutations and gene expression changes associated with cefiderocol heteroresistance, we subjected these variants to whole genome sequencing and global transcriptional analysis. We then assessed the impact of these mutations on the pharmacodynamic activity of cefiderocol via susceptibility testing, EDTA and boronic acid inhibition analysis, biofilm formation, and static time-kill assays. Heteroresistant variants AMA40 IHC1 and AMA40 IHC2 have 53 chromosomal mutations, of which 40 are common to both strains. None of the mutations occurred in genes associated with high affinity iron-uptake systems or β-lactam resistance. However, transcriptional analyses demonstrated significant modifications in levels of expression of genes associated with iron-uptake systems or β-lactam resistance. The bla(NDM-1) and bla(ADC-2,) as well as various iron-uptake system genes, were expressed at higher levels than the parental strain. On the other hand, the carO and ompA genes’ expression was reduced. One of the mutations common to both heteroresistant strains was mapped within ppiA, a gene associated with iron homeostasis in other species. Static time-kill assays demonstrated that supplementing cation-adjusted Mueller–Hinton broth with human serum albumin (HAS), the main protein component of HPF, considerably reduced cefiderocol killing activity for all three strains tested. Notably, collateral resistance to amikacin was observed in both variants. We conclude that exposing CRAB to fluids with high HSA concentrations facilitates the rise of heteroresistance associated with point mutations and transcriptional upregulation of genes coding for β-lactamases and biofilm formation. The findings from this study hold significant implications for understanding the emergence of CRAB resistance mechanisms against cefiderocol treatment. This understanding is vital for the development of treatment guidelines that can effectively address the challenges posed by CRAB infections. MDPI 2023-07-21 /pmc/articles/PMC10380697/ /pubmed/37511511 http://dx.doi.org/10.3390/ijms241411752 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mezcord, Vyanka
Escalante, Jenny
Nishimura, Brent
Traglia, German M.
Sharma, Rajnikant
Vallé, Quentin
Tuttobene, Marisel R.
Subils, Tomás
Marin, Ingrid
Pasteran, Fernando
Actis, Luis A.
Tolmasky, Marcelo E.
Bonomo, Robert A.
Rao, Gauri
Ramirez, María S.
Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
title Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
title_full Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
title_fullStr Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
title_full_unstemmed Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
title_short Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
title_sort induced heteroresistance in carbapenem-resistant acinetobacter baumannii (crab) via exposure to human pleural fluid (hpf) and its impact on cefiderocol susceptibility
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380697/
https://www.ncbi.nlm.nih.gov/pubmed/37511511
http://dx.doi.org/10.3390/ijms241411752
work_keys_str_mv AT mezcordvyanka inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT escalantejenny inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT nishimurabrent inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT tragliagermanm inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT sharmarajnikant inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT vallequentin inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT tuttobenemariselr inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT subilstomas inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT mariningrid inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT pasteranfernando inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT actisluisa inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT tolmaskymarceloe inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT bonomoroberta inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT raogauri inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility
AT ramirezmarias inducedheteroresistanceincarbapenemresistantacinetobacterbaumanniicrabviaexposuretohumanpleuralfluidhpfanditsimpactoncefiderocolsusceptibility